339 followers
RT @FrontImmunol: New Research: Pharmacokinetic characteristics of golidocitinib, a highly selective JAK1 inhibitor, in healthy adult parti…
RT @FrontImmunol: New Research: Pharmacokinetic characteristics of golidocitinib, a highly selective JAK1 inhibitor, in healthy adult parti…
New Research: Pharmacokinetic characteristics of golidocitinib, a highly selective JAK1 inhibitor, in healthy adult participants: Background Golidocitinib is an orally available, potent and highly selective JAK (Janus kinase)-1 inhibitor of… https://t.co/